Karyopharm Therapeutics
KPTI
KPTI
60 hedge funds and large institutions have $311M invested in Karyopharm Therapeutics in 2014 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 18 increasing their positions, 24 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
25% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 24
Holders
60
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$41.3M | |
| 2 | +$10.5M | |
| 3 | +$6.08M | |
| 4 |
BlackRock
New York
|
+$2.59M |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$2.48M |
Top Sellers
| 1 | -$19.6M | |
| 2 | -$4.14M | |
| 3 | -$3.91M | |
| 4 |
Morgan Stanley
New York
|
-$3.52M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.72M |